HEADER TRANSFERASE 21-JUN-18 6GVF TITLE CRYSTAL STRUCTURE OF PI3K ALPHA IN COMPLEX WITH 3-(2-AMINO- TITLE 2 BENZOOXAZOL-5-YL)-1-ISOPROPYL-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-YLAMINE COMPND MOL_ID: 1; COMPND 2 MOLECULE: PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC COMPND 3 SUBUNIT ALPHA ISOFORM; COMPND 4 CHAIN: A; COMPND 5 SYNONYM: PTDINS-3-KINASE SUBUNIT ALPHA,PHOSPHATIDYLINOSITOL 4,5- COMPND 6 BISPHOSPHATE 3-KINASE 110 KDA CATALYTIC SUBUNIT ALPHA,P110ALPHA, COMPND 7 PHOSPHOINOSITIDE-3-KINASE CATALYTIC ALPHA POLYPEPTIDE, COMPND 8 SERINE/THREONINE PROTEIN KINASE PIK3CA; COMPND 9 EC: 2.7.1.153,2.7.11.1; COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PIK3CA; SOURCE 6 EXPRESSION_SYSTEM: UNIDENTIFIED BACULOVIRUS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 10469 KEYWDS LIPID KINASE, INHIBITOR, PI3K ALPHA, TRANSFERASE-TRANSFERASE KEYWDS 2 INHIBITOR COMPLEX, TRANSFERASE-TRANSFERASE REGULATOR COMPLEX, KEYWDS 3 TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR G.OUVRY,M.AURELLY,L.BONNARY,E.BORDE,C.BOUIX-PETER,L.CHANTALAT, AUTHOR 2 L.CLARY,C.DEFOIN-PLATEL,S.DERET,M.FORISSIER,C.S.HARRIS,T.ISABET, AUTHOR 3 L.LAMY,A.P.LUZY,J.PASCAU,C.SOULET,A.TADDEI,N.TAQUET,L.TOMAS, AUTHOR 4 E.THOREAU,E.VARVIER,E.VIAL,L.F.HENNEQUIN REVDAT 2 04-DEC-19 6GVF 1 JRNL REVDAT 1 02-OCT-19 6GVF 0 JRNL AUTH G.OUVRY,L.CLARY,L.TOMAS,M.AURELLY,L.BONNARY,E.BORDE, JRNL AUTH 2 C.BOUIX-PETER,L.CHANTALAT,C.DEFOIN-PLATEL,S.DERET, JRNL AUTH 3 M.FORISSIER,C.S.HARRIS,T.ISABET,L.LAMY,A.P.LUZY,J.PASCAU, JRNL AUTH 4 C.SOULET,A.TADDEI,N.TAQUET,E.THOREAU,E.VARVIER,E.VIAL, JRNL AUTH 5 L.F.HENNEQUIN JRNL TITL IMPACT OF MINOR STRUCTURAL MODIFICATIONS ON PROPERTIES OF A JRNL TITL 2 SERIES OF MTOR INHIBITORS. JRNL REF ACS MED.CHEM.LETT. V. 10 1561 2019 JRNL REFN ISSN 1948-5875 JRNL PMID 31749911 JRNL DOI 10.1021/ACSMEDCHEMLETT.9B00401 REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.10.3 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 45.72 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 68.0 REMARK 3 NUMBER OF REFLECTIONS : 27740 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.195 REMARK 3 R VALUE (WORKING SET) : 0.193 REMARK 3 FREE R VALUE : 0.244 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.820 REMARK 3 FREE R VALUE TEST SET COUNT : 1337 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 14 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.60 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 6.08 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 259 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2577 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 250 REMARK 3 BIN R VALUE (WORKING SET) : 0.2522 REMARK 3 BIN FREE R VALUE : 0.4204 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 3.47 REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 7379 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 23 REMARK 3 SOLVENT ATOMS : 69 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 100.3 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 102.4 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -15.65340 REMARK 3 B22 (A**2) : 20.83630 REMARK 3 B33 (A**2) : -5.18290 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.350 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.352 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.932 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.911 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 7579 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 10261 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 2690 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES : 1277 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 7579 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 962 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 8524 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.14 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.65 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 21.38 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|* } REMARK 3 ORIGIN FOR THE GROUP (A): 2.6892 141.9140 19.7757 REMARK 3 T TENSOR REMARK 3 T11: -0.5004 T22: -0.0499 REMARK 3 T33: -0.4474 T12: -0.1296 REMARK 3 T13: 0.0127 T23: 0.0429 REMARK 3 L TENSOR REMARK 3 L11: 2.0874 L22: 1.8547 REMARK 3 L33: 2.2299 L12: 0.0887 REMARK 3 L13: -0.5534 L23: 0.3561 REMARK 3 S TENSOR REMARK 3 S11: 0.0167 S12: 0.4389 S13: 0.1364 REMARK 3 S21: -0.4470 S22: 0.0502 S23: -0.0952 REMARK 3 S31: -0.1950 S32: -0.2679 S33: -0.0669 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6GVF COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 21-JUN-18. REMARK 100 THE DEPOSITION ID IS D_1200010595. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 16-MAR-16 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SOLEIL REMARK 200 BEAMLINE : PROXIMA 1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97857 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 38749 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.500 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 68.0 REMARK 200 DATA REDUNDANCY : 7.600 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 13.5800 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.57 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.21 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.63 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 29.71000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 71.56000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 68.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 71.56000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 29.71000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 68.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 0 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 41070 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 0.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ILE A 311 REMARK 465 SER A 312 REMARK 465 THR A 313 REMARK 465 ALA A 314 REMARK 465 THR A 315 REMARK 465 PRO A 316 REMARK 465 TYR A 317 REMARK 465 MET A 318 REMARK 465 ASN A 319 REMARK 465 GLY A 320 REMARK 465 GLU A 321 REMARK 465 THR A 322 REMARK 465 SER A 323 REMARK 465 SER A 501 REMARK 465 ARG A 502 REMARK 465 GLU A 503 REMARK 465 ALA A 504 REMARK 465 GLY A 505 REMARK 465 PHE A 506 REMARK 465 LYS A 863 REMARK 465 GLY A 864 REMARK 465 GLY A 865 REMARK 465 LEU A 866 REMARK 465 LYS A 867 REMARK 465 GLY A 868 REMARK 465 ALA A 869 REMARK 465 LEU A 870 REMARK 465 GLN A 871 REMARK 465 PHE A 872 REMARK 465 LYS A 943 REMARK 465 LYS A 944 REMARK 465 PHE A 945 REMARK 465 GLY A 946 REMARK 465 TYR A 947 REMARK 465 LYS A 948 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 179 CG CD CE NZ REMARK 470 LYS A 187 CG CD CE NZ REMARK 470 LYS A 210 CG CD CE NZ REMARK 470 ARG A 230 CG CD NE CZ NH1 NH2 REMARK 470 MET A 232 CG SD CE REMARK 470 LYS A 240 CG CD CE NZ REMARK 470 GLU A 245 CG CD OE1 OE2 REMARK 470 LYS A 249 CG CD CE NZ REMARK 470 LYS A 325 CG CD CE NZ REMARK 470 ARG A 382 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 416 CG CD CE NZ REMARK 470 ARG A 519 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 941 CG CD CE NZ REMARK 470 LYS A 973 CG CD CE NZ REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 LEU A 177 CG CD1 CD2 REMARK 480 ASN A 331 CG OD1 ND2 REMARK 480 GLN A 530 CG CD OE1 NE2 REMARK 480 GLN A 546 CD OE1 NE2 REMARK 480 LYS A 588 CD CE NZ REMARK 480 SER A 774 OG REMARK 480 LEU A 881 CG CD1 CD2 REMARK 480 ILE A 913 CD1 REMARK 480 LYS A 986 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TYR A 167 73.34 -116.50 REMARK 500 SER A 199 121.85 -26.75 REMARK 500 ASN A 201 75.46 -64.64 REMARK 500 ASN A 202 64.57 6.42 REMARK 500 GLU A 237 -73.33 -73.80 REMARK 500 LEU A 239 78.28 47.36 REMARK 500 LEU A 244 15.13 55.66 REMARK 500 TYR A 246 67.12 8.62 REMARK 500 PHE A 261 79.75 -107.28 REMARK 500 LYS A 264 59.51 -69.00 REMARK 500 LEU A 339 -92.74 -77.77 REMARK 500 ASP A 350 -76.39 -83.04 REMARK 500 ASP A 390 49.75 -76.63 REMARK 500 ARG A 412 -40.59 -134.32 REMARK 500 ALA A 415 -167.21 -111.22 REMARK 500 GLU A 469 51.86 -98.97 REMARK 500 SER A 481 -9.38 59.28 REMARK 500 ASN A 521 44.48 79.29 REMARK 500 ASP A 589 56.18 -109.15 REMARK 500 TYR A 606 75.14 -117.19 REMARK 500 PRO A 757 6.57 -67.21 REMARK 500 ARG A 765 75.57 -109.57 REMARK 500 LYS A 776 6.75 84.47 REMARK 500 ARG A 777 66.61 36.29 REMARK 500 LEU A 793 -72.56 -129.23 REMARK 500 ASN A 885 69.72 -114.93 REMARK 500 ASP A 925 19.50 -67.45 REMARK 500 ASP A 933 93.12 49.69 REMARK 500 LEU A 938 -116.50 60.48 REMARK 500 MET A1010 108.76 -48.28 REMARK 500 ALA A1027 59.13 38.80 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue FE5 A 1101 DBREF 6GVF A 107 1051 UNP P42336 PK3CA_HUMAN 107 1051 SEQRES 1 A 945 ASN ARG GLU GLU LYS ILE LEU ASN ARG GLU ILE GLY PHE SEQRES 2 A 945 ALA ILE GLY MET PRO VAL CYS GLU PHE ASP MET VAL LYS SEQRES 3 A 945 ASP PRO GLU VAL GLN ASP PHE ARG ARG ASN ILE LEU ASN SEQRES 4 A 945 VAL CYS LYS GLU ALA VAL ASP LEU ARG ASP LEU ASN SER SEQRES 5 A 945 PRO HIS SER ARG ALA MET TYR VAL TYR PRO PRO ASN VAL SEQRES 6 A 945 GLU SER SER PRO GLU LEU PRO LYS HIS ILE TYR ASN LYS SEQRES 7 A 945 LEU ASP LYS GLY GLN ILE ILE VAL VAL ILE TRP VAL ILE SEQRES 8 A 945 VAL SER PRO ASN ASN ASP LYS GLN LYS TYR THR LEU LYS SEQRES 9 A 945 ILE ASN HIS ASP CYS VAL PRO GLU GLN VAL ILE ALA GLU SEQRES 10 A 945 ALA ILE ARG LYS LYS THR ARG SER MET LEU LEU SER SER SEQRES 11 A 945 GLU GLN LEU LYS LEU CYS VAL LEU GLU TYR GLN GLY LYS SEQRES 12 A 945 TYR ILE LEU LYS VAL CYS GLY CYS ASP GLU TYR PHE LEU SEQRES 13 A 945 GLU LYS TYR PRO LEU SER GLN TYR LYS TYR ILE ARG SER SEQRES 14 A 945 CYS ILE MET LEU GLY ARG MET PRO ASN LEU MET LEU MET SEQRES 15 A 945 ALA LYS GLU SER LEU TYR SER GLN LEU PRO MET ASP CYS SEQRES 16 A 945 PHE THR MET PRO SER TYR SER ARG ARG ILE SER THR ALA SEQRES 17 A 945 THR PRO TYR MET ASN GLY GLU THR SER THR LYS SER LEU SEQRES 18 A 945 TRP VAL ILE ASN SER ALA LEU ARG ILE LYS ILE LEU CYS SEQRES 19 A 945 ALA THR TYR VAL ASN VAL ASN ILE ARG ASP ILE ASP LYS SEQRES 20 A 945 ILE TYR VAL ARG THR GLY ILE TYR HIS GLY GLY GLU PRO SEQRES 21 A 945 LEU CYS ASP ASN VAL ASN THR GLN ARG VAL PRO CYS SER SEQRES 22 A 945 ASN PRO ARG TRP ASN GLU TRP LEU ASN TYR ASP ILE TYR SEQRES 23 A 945 ILE PRO ASP LEU PRO ARG ALA ALA ARG LEU CYS LEU SER SEQRES 24 A 945 ILE CYS SER VAL LYS GLY ARG LYS GLY ALA LYS GLU GLU SEQRES 25 A 945 HIS CYS PRO LEU ALA TRP GLY ASN ILE ASN LEU PHE ASP SEQRES 26 A 945 TYR THR ASP THR LEU VAL SER GLY LYS MET ALA LEU ASN SEQRES 27 A 945 LEU TRP PRO VAL PRO HIS GLY LEU GLU ASP LEU LEU ASN SEQRES 28 A 945 PRO ILE GLY VAL THR GLY SER ASN PRO ASN LYS GLU THR SEQRES 29 A 945 PRO CYS LEU GLU LEU GLU PHE ASP TRP PHE SER SER VAL SEQRES 30 A 945 VAL LYS PHE PRO ASP MET SER VAL ILE GLU GLU HIS ALA SEQRES 31 A 945 ASN TRP SER VAL SER ARG GLU ALA GLY PHE SER TYR SER SEQRES 32 A 945 HIS ALA GLY LEU SER ASN ARG LEU ALA ARG ASP ASN GLU SEQRES 33 A 945 LEU ARG GLU ASN ASP LYS GLU GLN LEU LYS ALA ILE SER SEQRES 34 A 945 THR ARG ASP PRO LEU SER GLU ILE THR GLU GLN GLU LYS SEQRES 35 A 945 ASP PHE LEU TRP SER HIS ARG HIS TYR CYS VAL THR ILE SEQRES 36 A 945 PRO GLU ILE LEU PRO LYS LEU LEU LEU SER VAL LYS TRP SEQRES 37 A 945 ASN SER ARG ASP GLU VAL ALA GLN MET TYR CYS LEU VAL SEQRES 38 A 945 LYS ASP TRP PRO PRO ILE LYS PRO GLU GLN ALA MET GLU SEQRES 39 A 945 LEU LEU ASP CYS ASN TYR PRO ASP PRO MET VAL ARG GLY SEQRES 40 A 945 PHE ALA VAL ARG CYS LEU GLU LYS TYR LEU THR ASP ASP SEQRES 41 A 945 LYS LEU SER GLN TYR LEU ILE GLN LEU VAL GLN VAL LEU SEQRES 42 A 945 LYS TYR GLU GLN TYR LEU ASP ASN LEU LEU VAL ARG PHE SEQRES 43 A 945 LEU LEU LYS LYS ALA LEU THR ASN GLN ARG ILE GLY HIS SEQRES 44 A 945 PHE PHE PHE TRP HIS LEU LYS SER GLU MET HIS ASN LYS SEQRES 45 A 945 THR VAL SER GLN ARG PHE GLY LEU LEU LEU GLU SER TYR SEQRES 46 A 945 CYS ARG ALA CYS GLY MET TYR LEU LYS HIS LEU ASN ARG SEQRES 47 A 945 GLN VAL GLU ALA MET GLU LYS LEU ILE ASN LEU THR ASP SEQRES 48 A 945 ILE LEU LYS GLN GLU LYS LYS ASP GLU THR GLN LYS VAL SEQRES 49 A 945 GLN MET LYS PHE LEU VAL GLU GLN MET ARG ARG PRO ASP SEQRES 50 A 945 PHE MET ASP ALA LEU GLN GLY PHE LEU SER PRO LEU ASN SEQRES 51 A 945 PRO ALA HIS GLN LEU GLY ASN LEU ARG LEU GLU GLU CYS SEQRES 52 A 945 ARG ILE MET SER SER ALA LYS ARG PRO LEU TRP LEU ASN SEQRES 53 A 945 TRP GLU ASN PRO ASP ILE MET SER GLU LEU LEU PHE GLN SEQRES 54 A 945 ASN ASN GLU ILE ILE PHE LYS ASN GLY ASP ASP LEU ARG SEQRES 55 A 945 GLN ASP MET LEU THR LEU GLN ILE ILE ARG ILE MET GLU SEQRES 56 A 945 ASN ILE TRP GLN ASN GLN GLY LEU ASP LEU ARG MET LEU SEQRES 57 A 945 PRO TYR GLY CYS LEU SER ILE GLY ASP CYS VAL GLY LEU SEQRES 58 A 945 ILE GLU VAL VAL ARG ASN SER HIS THR ILE MET GLN ILE SEQRES 59 A 945 GLN CYS LYS GLY GLY LEU LYS GLY ALA LEU GLN PHE ASN SEQRES 60 A 945 SER HIS THR LEU HIS GLN TRP LEU LYS ASP LYS ASN LYS SEQRES 61 A 945 GLY GLU ILE TYR ASP ALA ALA ILE ASP LEU PHE THR ARG SEQRES 62 A 945 SER CYS ALA GLY TYR CYS VAL ALA THR PHE ILE LEU GLY SEQRES 63 A 945 ILE GLY ASP ARG HIS ASN SER ASN ILE MET VAL LYS ASP SEQRES 64 A 945 ASP GLY GLN LEU PHE HIS ILE ASP PHE GLY HIS PHE LEU SEQRES 65 A 945 ASP HIS LYS LYS LYS LYS PHE GLY TYR LYS ARG GLU ARG SEQRES 66 A 945 VAL PRO PHE VAL LEU THR GLN ASP PHE LEU ILE VAL ILE SEQRES 67 A 945 SER LYS GLY ALA GLN GLU CYS THR LYS THR ARG GLU PHE SEQRES 68 A 945 GLU ARG PHE GLN GLU MET CYS TYR LYS ALA TYR LEU ALA SEQRES 69 A 945 ILE ARG GLN HIS ALA ASN LEU PHE ILE ASN LEU PHE SER SEQRES 70 A 945 MET MET LEU GLY SER GLY MET PRO GLU LEU GLN SER PHE SEQRES 71 A 945 ASP ASP ILE ALA TYR ILE ARG LYS THR LEU ALA LEU ASP SEQRES 72 A 945 LYS THR GLU GLN GLU ALA LEU GLU TYR PHE MET LYS GLN SEQRES 73 A 945 MET ASN ASP ALA HIS HIS GLY GLY TRP HET FE5 A1101 23 HETNAM FE5 5-(4-AZANYL-1-PROPAN-2-YL-PYRAZOLO[3,4-D]PYRIMIDIN-3- HETNAM 2 FE5 YL)-1,3-BENZOXAZOL-2-AMINE FORMUL 2 FE5 C15 H15 N7 O FORMUL 3 HOH *69(H2 O) HELIX 1 AA1 ASN A 107 GLY A 122 1 16 HELIX 2 AA2 VAL A 125 MET A 130 1 6 HELIX 3 AA3 ASP A 133 ILE A 143 1 11 HELIX 4 AA4 ILE A 143 ASP A 155 1 13 HELIX 5 AA5 PRO A 159 TYR A 167 1 9 HELIX 6 AA6 PRO A 178 ASN A 183 1 6 HELIX 7 AA7 LYS A 184 LYS A 187 5 4 HELIX 8 AA8 VAL A 216 ARG A 230 1 15 HELIX 9 AA9 LEU A 233 GLN A 238 1 6 HELIX 10 AB1 CYS A 242 GLN A 247 5 6 HELIX 11 AB2 PRO A 266 GLN A 269 5 4 HELIX 12 AB3 TYR A 270 GLY A 280 1 11 HELIX 13 AB4 LYS A 290 LEU A 297 1 8 HELIX 14 AB5 PRO A 305 ARG A 309 5 5 HELIX 15 AB6 TRP A 328 ILE A 330 5 3 HELIX 16 AB7 PRO A 394 LEU A 396 5 3 HELIX 17 AB8 ASP A 488 GLU A 494 1 7 HELIX 18 AB9 ARG A 524 ARG A 537 1 14 HELIX 19 AC1 THR A 544 HIS A 554 1 11 HELIX 20 AC2 TYR A 557 GLU A 563 5 7 HELIX 21 AC3 ILE A 564 LEU A 570 1 7 HELIX 22 AC4 SER A 576 ASP A 589 1 14 HELIX 23 AC5 LYS A 594 MET A 599 1 6 HELIX 24 AC6 GLU A 600 ASP A 603 5 4 HELIX 25 AC7 ASP A 608 LEU A 623 1 16 HELIX 26 AC8 THR A 624 VAL A 638 1 15 HELIX 27 AC9 LEU A 639 GLU A 642 5 4 HELIX 28 AD1 ASN A 647 ASN A 660 1 14 HELIX 29 AD2 ASN A 660 SER A 673 1 14 HELIX 30 AD3 VAL A 680 GLY A 696 1 17 HELIX 31 AD4 MET A 697 LYS A 723 1 27 HELIX 32 AD5 THR A 727 ARG A 740 1 14 HELIX 33 AD6 ARG A 741 LEU A 748 1 8 HELIX 34 AD7 ARG A 765 CYS A 769 5 5 HELIX 35 AD8 MET A 789 LEU A 793 5 5 HELIX 36 AD9 LEU A 807 ASN A 826 1 20 HELIX 37 AE1 MET A 858 ILE A 860 5 3 HELIX 38 AE2 HIS A 875 ASN A 885 1 11 HELIX 39 AE3 ILE A 889 GLY A 912 1 24 HELIX 40 AE4 THR A 957 SER A 965 1 9 HELIX 41 AE5 THR A 974 HIS A 994 1 21 HELIX 42 AE6 HIS A 994 MET A 1005 1 12 HELIX 43 AE7 LEU A 1006 SER A 1008 5 3 HELIX 44 AE8 SER A 1015 ALA A 1020 1 6 HELIX 45 AE9 ALA A 1020 LEU A 1026 1 7 HELIX 46 AF1 THR A 1031 HIS A 1048 1 18 SHEET 1 AA1 5 ASP A 203 ASN A 212 0 SHEET 2 AA1 5 GLN A 189 VAL A 198 -1 N VAL A 192 O LEU A 209 SHEET 3 AA1 5 ASN A 284 ALA A 289 1 O LEU A 285 N VAL A 193 SHEET 4 AA1 5 TYR A 250 VAL A 254 -1 N LYS A 253 O MET A 286 SHEET 5 AA1 5 TYR A 260 PHE A 261 -1 O PHE A 261 N LEU A 252 SHEET 1 AA2 2 LYS A 325 SER A 326 0 SHEET 2 AA2 2 VAL A 484 LYS A 485 1 O LYS A 485 N LYS A 325 SHEET 1 AA3 4 ARG A 382 TYR A 392 0 SHEET 2 AA3 4 ALA A 333 THR A 342 -1 N ILE A 336 O LEU A 387 SHEET 3 AA3 4 CYS A 472 PHE A 477 -1 O GLU A 476 N LYS A 337 SHEET 4 AA3 4 GLY A 439 ASN A 444 -1 N MET A 441 O LEU A 475 SHEET 1 AA4 3 GLU A 365 PRO A 366 0 SHEET 2 AA4 3 LYS A 353 HIS A 362 -1 N HIS A 362 O GLU A 365 SHEET 3 AA4 3 VAL A 371 ASN A 372 -1 O VAL A 371 N THR A 358 SHEET 1 AA5 5 GLU A 365 PRO A 366 0 SHEET 2 AA5 5 LYS A 353 HIS A 362 -1 N HIS A 362 O GLU A 365 SHEET 3 AA5 5 ARG A 401 LYS A 410 -1 O CYS A 407 N TYR A 355 SHEET 4 AA5 5 GLU A 418 ASN A 428 -1 O GLY A 425 N LEU A 404 SHEET 5 AA5 5 TRP A 446 PRO A 447 -1 O TRP A 446 N TRP A 424 SHEET 1 AA6 2 PHE A 751 LEU A 752 0 SHEET 2 AA6 2 GLN A 760 LEU A 761 -1 O LEU A 761 N PHE A 751 SHEET 1 AA7 5 ARG A 770 ILE A 771 0 SHEET 2 AA7 5 LEU A 779 GLU A 784 -1 O TRP A 780 N ARG A 770 SHEET 3 AA7 5 ASN A 796 ASN A 803 -1 O ILE A 799 N LEU A 781 SHEET 4 AA7 5 VAL A 845 GLU A 849 -1 O ILE A 848 N ILE A 800 SHEET 5 AA7 5 CYS A 838 SER A 840 -1 N LEU A 839 O LEU A 847 SHEET 1 AA8 3 SER A 854 THR A 856 0 SHEET 2 AA8 3 ILE A 921 LYS A 924 -1 O VAL A 923 N HIS A 855 SHEET 3 AA8 3 LEU A 929 HIS A 931 -1 O PHE A 930 N MET A 922 CISPEP 1 SER A 158 PRO A 159 0 3.99 CISPEP 2 PRO A 200 ASN A 201 0 9.19 CISPEP 3 GLY A 411 ARG A 412 0 -0.86 SITE 1 AC1 11 MET A 772 LYS A 802 ASP A 810 TYR A 836 SITE 2 AC1 11 ILE A 848 GLU A 849 VAL A 850 VAL A 851 SITE 3 AC1 11 THR A 856 MET A 922 ASP A 933 CRYST1 59.420 136.000 143.120 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016829 0.000000 0.000000 0.00000 SCALE2 0.000000 0.007353 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006987 0.00000